Prof. Dr. Lisa Maier has been appointed to the professorship ‘Microbiome-Host Interactions’ at the Faculty of Medicine in April 2022. She completed her studies in biochemistry at the University of Tübingen (2004-2009) and her PhD in the laboratory of Wolf-Dietrich Hardt at ETH Zurich (2014). As part of the interdisciplinary postdoctoral program at EMBL in Heidelberg, she worked in the groups of Nassos Typas and Kiran Patil (2015-2018). In 2019, she returned to Tübingen as CMFI and Emmy Noether junior research group leader. Her lab uses automated high-throughput and multi-readout approaches to systematically study the lifestyle of bacteria in the human microbiome. The resulting datasets are then used as a starting point for mechanistic studies to uncover the molecular details of how the microbiome interacts with its host.
Prof. Dr. Hannes Link is professor for Bacterial Metabolomics at the University of Tübingen from October 2020. He studied chemical-engineering at the Technical University Munich from 2000-2005 and received his PhD from the Department of Biochemical Engineering of the TU Munich in 2009. After 5 years as a postdoc with Prof. Uwe Sauer at the ETH Zurich, he headed an Emmy Noether research group at the MPI for Terrestrial Microbiology in Marburg from 2015-2020. His research group investigates metabolic networks and interactions between metabolites and regulators of gene expression. The aim of his research is to engineer bacterial metabolism for biotechnological and medical applications. This work includes the development of metabolomics methods to quantify metabolites and metabolic fluxes.
Ana Rita Brochado has been appointed to the junior professorship 'Drug-Microbiome Interaction' at the Faculty of Mathematics and Natural Sciences in April, 2023. She studied 2002–2008 Biological Engineering at the University of Lisbon and completed her PhD at the Technical University of Denmark in 2012. As a postdoc, she worked in the group of Nassos Typas at the European Molecular Biology Laboratory in Heidelberg (EMBL). In 2019, she established her own Emmy Noether junior research group at the University of Würzburg to study the effects of antibiotics on important pathogenic bacteria. The Hector Fellow Academy accepted Brochado into its funding program and she was awarded the Research Career Development Award in 2020. In 2021 the University of Würzburg honored her for her research with the “Röntgen Prize”. In her work, Ana Rita Brochado explores the question of what influence the entire environment has on the effect of antibiotics. It has long been clear that it is not only the type and dosage of antibiotics that determine their effect on bacteria, but also other bacteria and substances. With her research group, Brochado combines different approaches from systems biology. Molecular biological analysis can provide clues as to how resistance to antibiotics can be outwitted by a combination of different active ingredients.
Prof. Dr. Reiner Jumpertz-von Schwartzenberg has accepted the appointment to the professorship for Clinical Metabolism and Obesity Research at the Faculty of Medicine in the summer semester of 2022. He studied medicine in Bochum and Leipzig, where he received his doctorate in 2012. During his subsequent stays abroad as a visiting scientist at the National Institute of Health (NIH) in the USA and the University of California/San Francisco, he deepened his research on obesity, diabetes and the gut microbiome. Since 2021, Jumpertz-von Schwartzenberg has been senior physician for diabetology, endocrinology and nephrology as well as head of the study centre of the Institute for Diabetes Research and Metabolic Diseases at the University Hospital Tübingen. He also leads a Helmholtz Young Investigator Group and is junior research group leader in the Cluster of Excellence "Controlling Microbes to Fight Infections" (CMFI) in Tübingen, where he investigates the mechanisms underlying the development of metabolic diseases. The focus is on the interactions between the gut microbiome and host metabolism in the context of intestinal food absorption.
Prof. Dr. med. univ. Christoph Stein-Thoeringer, has been professor of Clinical Infectiology and Translational Microbiome Research at Tübingen University Hospital since July 2022.
He studied medicine at the University of Zurich and subsequently at the University of Graz, where he completed his PhD in human medicine in 2005.
He then spent three years as a postdoctoral fellow with Dr. C. Wotjak at the Max Planck Institute of Psychiatry in Munich, before becoming a resident and research group leader at the Technical University of Munich, where he focused on functional and inflammatory bowel diseases. As a postdoctoral fellow at Memorial Sloan Kettering Cancer Center (MSKCC) in New York, he deepened his research on the gut microbiome and cancer immunotherapies.
From 2019 to 2022, Christoph Stein-Thoeringer was principal investigator in the Department of Microbiome and Cancer at the German Cancer Research Center (DKFZ) in Heidelberg, Germany. From 2020 to 2022 he was a member of the National Center for Tumor Diseases (NCT) and part of NCT’s Board of Directors.
Since 2022, Christoph Stein-Thoeringer has been part of the senior medical division management of infectious diseases at the University Hospital Tübingen, head of the DZIF Clinical Research Unit, working group leader in translational microbiome research, and professor of Clinical Infectious Diseases and Translational Microbiome Research.